Vimarsana
Biggest News Aggregation in the World

Page 3 - Alan Daugherty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Alan Daugherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Alan Daugherty Today - Breaking & Trending Today

UK's Daugherty honored for transformative work with American Heart Association journal - Vimarsana News

UK's Daugherty honored for transformative work with American Heart Association journal

In addition to his many roles at the University of Kentucky, Alan Daugherty, Ph.D., D. Sc., has also spent decades working with the American Heart Association. For the past 10 years, he's served as editor-in-chief of the journal Arteriosclerosis, Thrombosis, and Vascular Biology, and will be honored for his achievements.

Source: uky.edu
Gill Foundation honors researchers for excellence in cardiovascular research and medicine - Vimarsana News

Gill Foundation honors researchers for excellence in cardiovascular research and medicine

The awards will be presented at the 25th annual University of Kentucky Gill Heart and Vascular Institute Cardiovascular Research Day on Oct. 20, 2023, at the Central Bank Center.

Source: uky.edu
Project to restore the Craigville Depot brings back a railroad gem - Vimarsana News

Project to restore the Craigville Depot brings back a railroad gem

A local railroad depot that sat decaying for decades is ready to greet the new year dressed in its holiday best.

American Heart Association honors UK researcher's impact on cardiovascular health - Vimarsana News

American Heart Association honors UK researcher's impact on cardiovascular health

Alan Daugherty, Ph.D., D.Sc., was named the 2022 George Lyman Duff Memorial Lecturer at the American Heart Association’s Scientific Sessions.

Source: uky.edu
Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022 - Vimarsana News

Progress Reported on Clinical Trials of Genomic Profiling for Cardiovascular Disease at AHA 2022

New genomic therapies for cardiovascular disease are reaching the clinical trial stage, according to moderators of a session presented at the American Heart Association Annual Scientific Session (AHA2022).